Inhibition of Wnt signaling pathway decreases chemotherapy-resistant side-population colon cancer cells

Anticancer Research

Volumn 30, Issue 6, 2010, Pages 2041-2048

  Chikazawa, Nobuhito ^a   Tanaka, Haruo ^a   Tasaka, Takehiko ^a   Nakamura, Masafumi ^a   Tanaka, Masao ^a   Onishi, Hideya ^a   Katano, Mitsuo ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

ATP binding cassette transporter; Colon cancer; Side population; Wnt signaling

Indexed keywords

7 ETHYL 10 HYDROXYCAMPTOTHECIN; BETA CATENIN; BREAST CANCER RESISTANCE PROTEIN; FLUOROURACIL; IRINOTECAN; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN 1; PACLITAXEL; SMALL INTERFERING RNA; WNT PROTEIN;

ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CANCER GROWTH; CELL POPULATION; COLON CANCER; DRUG SENSITIVITY; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; INHIBITION KINETICS; INTRACELLULAR SIGNALING; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SIDE POPULATION CELL; WESTERN BLOTTING;

ATP-BINDING CASSETTE TRANSPORTERS; BETA CATENIN; CELL LINE, TUMOR; COLONIC NEOPLASMS; DRUG RESISTANCE, NEOPLASM; HUMANS; NEOPLASM PROTEINS; P-GLYCOPROTEIN; SIGNAL TRANSDUCTION; WNT PROTEINS;

EID: 77955078486     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C and Thun MJ: Cancer statistics, 2006. CA Cancer J Clin 56: 106-130, 2006.
2. Van Cutsem E and Costa F: Progress in the adjuvant treatment of colon cancer: Has it influenced clinical practice? JAMA 294: 2758-2760, 2005.
3. Goodell MA, Brose K, Paradis G, Conner AS and Mulligan RC: Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J Exp Med 183: 1797-1806, 1996.
4. Haraguchi N, Utsunomiya T, Inoue H, Tanaka F, Mimori K, Barnard GF and Mori M: Characterization of a side population of cancer cells from human gastrointestinal system. Stem Cells 24: 506-513, 2006.
5. Burkert J, Otto WR and Wright NA: Side populations of gastrointestinal cancers are not enriched in stem cells. J Pathol 214: 564-573, 2008.
6. Hadnagy A, Gaboury L, Beaulieu R and Balicki D: SP analysis may be used to identify cancer stem cell populations. Exp Cell Res 312: 3701-3710, 2006.
7. Wu C and Alman BA: Side population cells in human cancers. Cancer Lett 268: 1-9, 2008.
8. Zhou S, Schuetz JD, Bunting KD, Colapietro AM, Sampath J, Morris JJ, Lagutina I, Grosveld GC, Osawa M, Nakauchi H and Sorrentino BP: The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nat Med 7: 1028-1034, 2001.
9. Dean M, Rzhetsky A and Allikmets R: The human ATP-binding cassette (ABC) transporter superfamily. Genome Res 11: 1156-1166, 2001.
10. Schinkel AH, Smit JJ, van Tellingen O, Beijnen JH, Wagenaar E, van Deemter L, Moi CA, van der Valk MA, Robanus-Maandag EC, te Riele HP, Berns AJ and Borst P: Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell 77: 491-502, 1994.
11. Zhou S, Zong Y, Lu T and Sorrentino BP: Hematopoietic cells from mice that are deficient in both Bcrp1/Abcg2 and Mdr1a/1b develop normally but are sensitized to mitoxantrone. Biotechniques 35: 1248-1252, 2003.
12. Dean M, Fojo T and Bates S: Tumour stem cells and drug resistance. Nat Rev Cancer 5: 275-284, 2005.
13. Bertolini G, Roz L, Perego P, Tortoreto M, Fontanella E, Gatti L, Pratesi G, Fabbri A, Andriani F, Tinelli S, Roz E, Caserini R, Lo Vullo S, Camerini T, Mariani L, Delia D, Calabrò E, Pastorino U and Sozzi G: Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment. Proc Natl Acad Sci USA 106: 16281-16286, 2009.
14. Kim M, Turnquist H, Jackson J, Sgagias M, Yan Y, Gong M, Dean M, Sharp JG and Cowan K: The multidrug resistance transporter ABCG2 (breast cancer resistance protein 1) effluxes Hoechst 33342 and is overexpressed in hematopoietic stem cells. Clin Cancer Res 8: 22-28, 2002.
15. Wang YH, Li L, Luo B, Wang XH, Sun HC, Liu S, Cui YQ and Xu XX: A side population of cells from a human pancreatic carcinoma cell line harbors cancer stem cell characteristics. Neoplasm 56: 371-378, 2009.
16. Fodde R, Smits R and Clevers H: APC, signal transduction and genetic instability in colorectal cancer. Nat Rev Cancer 1: 55-67, 2001.
17. Polakis P: Wnt signaling and cancer. Genes Dev 14: 1837-1851, 2000.
18. He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, Morin PJ, Vogelstein B and Kinzler KW: Identification of c-MYC as a target of the APC pathway. Science 281: 1509-1512, 1998.
19. Tetsu O and McCormick F: β-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 398: 422-426, 1999.
20. Morin PJ, Sparks AB, Korinek V, Barker N, Cleavers H, Vogelstein B and Kinzler KW: Activation of β-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science 275: 1787-1790, 1997.
21. -/- colon carcinoma. Science 275: 1784-1787, 1997.
22. Yamada T, Takaoka AS, Naishiro Y, Hayashi R, Maruyama K, Maesawa C, Ochiai A and Hirohashi S: Transactivation of the multidrug resistance 1 gene by T-cell factor 4/β-catenin complex in early colorectal carcinogenesis. Cancer Res 60: 4761-4766, 2000.
23. Longo KA, Kennell JA, Ochocinska MJ, Ross SE, Wright WS and MacDougald OA: Wnt signaling protects 3T3-L1 preadipocytes from apoptosis through induction of insulin-like growth factors. J Biol Chem 277: 38239-38244, 2002.
24. Lim JC, Kania KD, Wijesuriya H, Chawla S, Sethi JK, Pulaski L, Romero IA, Couraud PO, Weksler BB, Hladky SB and Barrand MA: Activation of β-catenin signalling by GSK-3 inhibition increases p-glycoprotein expression in brain endothelial cells. J Neurochem 106: 1855-1865, 2008.
25. Flahaut M, Meier R, Coulon A, Nardou KA, Niggli FK, Martinet D, Beckmann JS, Joseph JM, Mühlethaler-Mottet A and Gross N: The Wnt receptor FZD1 mediates chemoresistance in neuroblastoma through activation of the Wnt/β-catenin pathway. Oncogene 28: 2245-2256, 2009.
26. Bienz M and Clevers H: Linking colorectal cancer to Wnt signaling. Cell 103: 311-320, 2000.
27. Groden J, Thliveris A, Samowitz W, Carlson M, Gelbert L, Albertsen H, Joslyn G, Stevens J, Spirio L, Robertson M, Sargeant L, Krapcho K, Wolff E, Burt R, Hughes JP, Warrington J, McPherson J, Wasmuth J, Le Paslier D, Abderrahim H, Cohen D, Leppert M and White R: Identification and characterization of the familial adenomatous polyposis coli gene. Cell 66: 589-600, 1991.
28. Segditsas S and Tomlinson I: Colorectal cancer and genetic alterations in the Wnt pathway. Oncogene 25: 7531-7537, 2006.
29. Thenappan A, Li Y, Shetty K, Johnson L, Reddy EP and Mishra L: New Therapeutics Targeting Colon Cancer Stem Cells. Curr Colorectal Cancer Rep 5: 209-216, 2009.
30. Ling V: Multidrug resistance and P-glycoprotein expression. Ann NY Acad Sci 507: 7-8, 1987.
31. Roninson IB, Chin JE, Choi KG, Gross P, Housman DE, Fojo A, Shen DW, Gottesam MM and Pastan I: Isolation of human mdr DNA sequences amplified in multidrug-resistant KB carcinoma cells. Proc Natl Acad Sci USA 83: 4538-4542, 1986.
32. Robey RW, Polgar O, Deeken J, To KW and Bates SE: ABCG2: determining its relevance in clinical drug resistance. Cancer Metastasis Rev 26: 39-57, 2007.
33. - cancer cells are similarly tumorigenic. Cancer Res 65: 6207-6219, 2005.
34. Kato K, Yoshimoto M, Kato K, Adachi S, Yamayoshi A, Arima T, Asano K, Kyo S, Nakahata T and Wake N: Characterization of side-population cells in human normal endometrium. Hum Reprod 22: 1214-1223, 2007.
35. Sussman RT, Ricci MS, Hart LS, Sun SY and El-Deiry WS: Chemotherapy-resistant side-population of colon cancer cells has a higher sensitivity to TRAIL than the non-SP, a higher expression of c-Myc and TRAIL-receptor DR4. Cancer Biol Ther 6: 1490-5, 2007.
36. Szakács G, Annereau JP, Lababidi S, Shankavaram U, Arciello A, Bussey KJ, Reinhold WR, Guo Y, Kruh GD, Reimers M, Weinstein JN and Gottesman MM: Predicting drug sensitivity and resistance: profiling ABC transporter genes in cancer cells. Cancer Cell 6: 129-137, 2004.
37. Doyle LA and Ross DD: Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2). Oncogene 22: 7340-7358, 2003.
38. -/low subpopulation and the side population of breast cancer cells. Anticancer Res 29: 2147-2157, 2009.
39. Hannon GJ: RNA interference: Nature 418: 244-251, 2002.
40. Wu H, Hait WN and Yang JM: Small interfering RNA-induced suppression of MDR1 (P-glycoprotein) restores sensitivity to multidrug-resistant cancer cells. Cancer Res 63: 1515-1519, 2003.